Relmada Therapeutics Presents Development Program of REL1017 for Treatment of Depression at the 2019 American Society of Clinical Psychopharmacology Meeting
Stock Information for Relmada Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.